Are We Waiting for Developments In Cancer Research or Is Developments In Cancer Research Waiting For

There are many websites on the world wide web, which are excellent newsfeeds for the latest clinical news, clinical research in medical development and dense in medical data, with well written articles. An article I stumbled across on one of my many quests into scouring the web for Clinical articles on developments in to cancer research that happened to of caught my eye was a piece by Catherine Paddock titled "Advanced Melanoma: Using Patients' Own Anti-Tumor Cells Holds Treatment Promise" and would definitely recommend others to have a read. It is encouraging to see further signs of breakthrough in cancer research. 

 "Results of a small trial published online on 5 March in the Proceedings of the National Academy of Sciences, where patients with progressive metastatic melanoma were treated with billions of lab-grown clones of the their own anti-tumor cells, are raising hopes that a treatment can be developed to knock back the advanced form of this most dangerous skin cancer. 
 
Melanoma is a type of cancer that develops in the pigment-producing cells of the skin. Metastatic melanoma is melanoma that has spread to other parts of the body, such as the tissue that lies beneath the skin, the lymph nodes, or to organs like the lungs, liver, brain and bones. 
 
The small, early-phase trial involved 11 patients, and was led Dr Cassian Yee of the Clinical Research Divison of Fred Hutchinson Cancer Research Center in Seattle in the US". 

 
Recent clinical studies are promising and offer hope for those that have been or will be affected by cancer. Another Clinical article I found interesting yet raised more questions than answers was was written by Nigel Praities on 24th February 2012 titled "Study Reveals GP Diagnoses Delays For Different Cancers".  
 
"UK researchers have called for better training and support for GPs after they uncovered ‘large variation' in the number of pre-referral consultations for certain cancers. New data from 41,000 patients in the National Cancer Patient Experience Survey – published in lance today – show significant delays in the diagnosis of multiple myeloma, pancreatic cancer, stomach cancer and lung cancer in primary care. Patients with these four cancers were more likely to have had three or more pre-referral consultations with their GP, with odds ratios of 3.42, 2.35, 1.96 and 1.68 respectively. In contrast other cancers were more promptly referred. Breast cancer, melanoma, testicular cancer and endometrial cancer more likely to be referred to hospital after one or two consultations, with odds ratios of 0.19, 0.34, 0.47 and 0.59 respectively". 
 
It seems that for years we have been waiting for development in medical research and ways of new treatments but could it be that now medical research is now waiting for us?